本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

4.62
+0.06001.32%
盘后4.620.00000.00%19:05 EDT
成交量:345.91万
成交额:1,595.34万
市值:3.16亿
市盈率:-2.37
高:4.64
开:4.57
低:4.49
收:4.56
数据加载中...
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/23

重要事件披露

Form 8-K - Current report
2023/10/19

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/10/17

重要事件披露

Form 8-K - Current report
2023/10/10

重要事件披露

Form 8-K - Current report
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/05

重要事件披露

Form 8-K - Current report
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities